• Poster

A Q-TWiST Analysis of Lapatinib Plus Letrozole Compared With Letrozole Alone as First-Line Therapy in Hormone Receptor Positive (HR+) Metastatic Breast Cancer (MBC)

Citation

Sherrill, B., Amonkar, M., Sherif, B. N., Maltzman, J., O'Rourke, L., & Johnston, S. (2009, September). A Q-TWiST Analysis of Lapatinib Plus Letrozole Compared With Letrozole Alone as First-Line Therapy in Hormone Receptor Positive (HR+) Metastatic Breast Cancer (MBC). Presented at The Joint 15th Congress of the European Cancer Organization and 34th Congress of the European Society for Medical Oncology, .

Abstract